Rel-Ceperognastat

• Description:

  Rel-Ceperognastat (rel-LY3372689) (Compound Formula Ic) is a O-GlcNAcase (OGA) inhibitor that can be used to study the neurodegenerative diseases and disorders, such as Alzheimer's disease[1].

• Product Name Alternative:

  Rel-LY3372689

• UNSPSC:

  12352005

• Target:

  OGA; Tau Protein

• Type:

  Reference compound

• Related Pathways:

  Neuronal Signaling

• Applications:

  Neuroscience-Neurodegeneration

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/rel-ly3372689.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CC(NC1=NC(F)=C(S1)CN2[C@@H](C[C@@H](CC2)OCC3=NOC(C)=N3)C)=O

• Molecular Formula:

  C16H22FN5O3S

• Molecular Weight:

  383.44

• References & Citations:

  [1]Nicolas Jacques Francois Dreyfus, et al. N-[4-fluoro-5-[[ (2s,4s) -2-methyl-4-[ (5-methyl-1,2,4-oxadiazol-3-yl) methoxy]-1-piperidyl]methyl]thiazol-2-yl]acetamide as oga inhibitor. WO2018140299A1.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  2241514-58-7